Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

NCT00660764 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00660764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00660764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2003
Completion date
April 30, 2005
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident, coronary heart disease, diabetes, hypercholesterolemia, peripheral vascular disease